Zawada Stephanie J, Aissa Naser Haj, Conte Gian Marco, Pollock Benjamin D, Athreya Arjun P, Erickson Bradley J, Demaerschalk Bart M
Mayo Clinic College of Medicine and Science, Scottsdale, AZ.
Department of Neurology, Mayo Clinic, Scottsdale, AZ.
Mayo Clin Proc Digit Health. 2023 Apr 25;1(2):139-160. doi: 10.1016/j.mcpdig.2023.03.007. eCollection 2023 Jun.
Cerebrovascular disease (CeVD) is a leading cause of death and disability worldwide. Early detection of behavioral and physiologic changes associated with CeVD may be critical to improving patient outcomes. The growing prevalence of remote monitoring tools, from wearable devices to smartphone applications, which facilitate observation of patients, holds promise for more timely recognition and possible prevention of stroke. The goal of this review was to examine and establish categories of innovation with digital sensors that monitor physiologic and behavioral variables to augment the current CeVD screening and diagnostic processes. Guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist, a search strategy spanning multiple databases from January 2012 to September 30, 2022, was implemented, aggregating 729 articles, of which 51 (7.0%) met the inclusion criteria. The articles were divided into 2 categories on the basis of their focus: physiologic and behavioral. Physiologic articles were sorted into 1 of the following 6 subcategories according to the signal(s) monitored: motor function, heart rhythm, heart rate, kinematic analysis, physical activity, and blood pressure. Behavioral articles were sorted into the following 3 subcategories: mood, cognitive function, and fatigue. Most studies used a wearable accelerometer, photoplethysmography-enabled smartwatch, or smartphone-based sensors. This scoping review identified disparate methods and conclusions associated with the use of digital sensors for physiologic and behavioral monitoring of patients with CeVD. Although most articles evaluated pilot validation and feasibility trials, the lack of randomized controlled trials was identified as a critical gap specific to this evolving research area.
脑血管疾病(CeVD)是全球死亡和残疾的主要原因。早期发现与CeVD相关的行为和生理变化对于改善患者预后可能至关重要。从可穿戴设备到智能手机应用程序等远程监测工具的日益普及,有助于对患者进行观察,有望更及时地识别并可能预防中风。本综述的目的是研究并确定使用数字传感器监测生理和行为变量的创新类别,以增强当前CeVD的筛查和诊断流程。以系统评价和Meta分析的首选报告项目清单为指导,实施了一项检索策略,检索了2012年1月至2022年9月30日期间多个数据库,共汇总了729篇文章,其中51篇(7.0%)符合纳入标准。这些文章根据其重点分为两类:生理类和行为类。生理类文章根据所监测的信号分为以下6个子类别之一:运动功能、心律、心率、运动学分析、身体活动和血压。行为类文章分为以下3个子类别:情绪、认知功能和疲劳。大多数研究使用了可穿戴加速度计、具备光电容积脉搏波描记法的智能手表或基于智能手机的传感器。本范围综述确定了与使用数字传感器对CeVD患者进行生理和行为监测相关的不同方法和结论。尽管大多数文章评估了初步验证和可行性试验,但随机对照试验的缺乏被确定为这一不断发展的研究领域的一个关键差距。